Ustekinumab Drug Monitoring Predictive of Disease Activity in Crohn Disease
Researchers sought to identify predictive markers of ustekinumab response as well as evaluate the effect of its pharmacokinetics on the clinical and endoscopic outcomes among patients with Crohn disease.